Should We Expand Cardiac Response Criteria in Patients with Light Chain Cardiac Amyloidosis?
J Am Soc Echocardiogr
.
2021 Mar;34(3):318-322.
doi: 10.1016/j.echo.2020.11.016.
Epub 2020 Dec 2.
Authors
Jorge V López-Ibor
1
,
Isabel Krsnik
2
,
Manuel Gómez-Bueno
1
,
Francisco J Hernández-Pérez
1
,
Alejandro Durante-López
1
,
Susana Mingo Santos
1
,
Vanessa Moñivas Palomero
1
,
Eusebio García-Izquierdo
1
,
Inés Sayago
3
,
Ana Royuela
4
,
Javier Segovia-Cubero
1
Affiliations
1
Advanced Heart Failure and Heart Transplantation Unit, Department of Cardiology, Hospital Puerta de Hierro Majadahonda, Madrid, Spain.
2
Department of Hematology, Hospital Puerta de Hierro Majadahonda, Madrid, Spain.
3
Advanced Heart Failure and Heart Transplantation Unit, Department of Cardiology, Hospital Virgen del Rocío, Sevilla, Spain.
4
Biostatistics Unit, Puerta de Hierro Biomedical Research Institute, CIBERESP, Madrid, Spain.
PMID:
33276078
DOI:
10.1016/j.echo.2020.11.016
No abstract available
MeSH terms
Amyloidosis* / diagnosis
Cardiomyopathies* / diagnosis
Heart
Humans
Immunoglobulin Light-chain Amyloidosis*